Alligator, Aptevo Partner on Bispecific Cancer Immunotherapy … – Genetic Engineering & Biotechnology News (blog)
|
Alligator, Aptevo Partner on Bispecific Cancer Immunotherapy …
Genetic Engineering & Biotechnology News (blog) Swedish firm Alligator Bioscience and Seattle-based Aptevo Therapeutics have agreed to co-develop ALG.APV-527, a bispecific antibody for tumor-directed … Alligator Bioscience AB: Aptevo Therapeutics and Alligator …GlobeNewswire (press release) |
|
A vibrant synthetic biology ecosystem has developed in the UK – promising new jobs and valuable technology
PharmiWeb.com (press release) London, UK, 21st July 2017 / Sciad Newswire / A survey of synthetic biology company start-ups in the UK is published today by SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology. The study reveals a vibrant ecosystem … |
pharmaphorum |
New 3 year data supports Kite ‘cure’ hopes for CAR–T
pharmaphorum The study involved Kite’s own CAR–T candidate KTE019, which will soon be reviewed by the FDA in in patients with aggressive NHL including diffuse large B-cell lymphoma (DLBCL). Kite is chasing Novartis, which just two weeks ago received a landmark … |
